Search
for

    Research 10 of 280

    1. Postmarketing Surveillance of New Antiepileptic Drugs: The Tribulations of Trials Epilepsia · 2002 · 12 citations
    2. Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study Drugs - Real World Outcomes · 2019 · 8 citations
    3. Changes in European Legislation Make it Timely to Introduce a Transparent Market Surveillance System for Cosmetics Acta dermato-venereologica · 2007 · 12 citations
    4. Failing Public Health Again? Analytical Review of Depression and Suicidality From Finasteride The Journal of Clinical Psychiatry · 2025
    5. Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies Expert Opinion on Drug Safety · 2018
    6. A Real‐World Disproportionality Analysis of Avacopan in Anti‐Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting System Pharmacology Research & Perspectives · 2025 · 2 citations
    7. Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors Journal of clinical and investigative dermatology · 2014 · 2 citations
    8. Ethinylestradiol/Chlormadinone Acetate Drugs · 2004 · 1 citations
    9. Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study Journal of Dermatological Treatment · 2026 · 2 citations
    10. Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants Annals of General Psychiatry · 2023 · 11 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →